Mouth sores from cancer therapy can be brutal, making it hard to eat, talk, or even think. A new review of 329 cancer patients getting chemotherapy or radiation found that photobiomodulation therapy, a type of light treatment, is highly effective at managing these sores. The analysis showed it significantly reduces how often they happen and how severe they get. This matters for patients who often stop treatment because of the pain. The review also suggests this therapy can improve quality of life and help people stick with their cancer treatment. The evidence comes from pooling data from several randomized clinical trials. However, the light therapy protocols varied between studies, using different wavelengths and application times. The findings show an association, not direct proof that the therapy causes the improvement. Still, the overall evidence is considered strong and from recent trials with low risk of bias.
Photobiomodulation therapy reduces oral mucositis in cancer patients
Photo by National Cancer Institute / Unsplash
What this means for you:
Light therapy can significantly reduce painful mouth sores for cancer patients on treatment. More on Oral Mucositis
Network meta-analysis of interventions for oral mucositis in breast cancer patients Zinc and Honey Extract Beat Costly Treatments for Cancer Mouth Sores
· May 9, 2026
Modified oral cryotherapy protocol associated with reduced pain in HSCT recipients with oral mucositis Modified cooling protocol linked to less severe mouth pain after stem cell transplant
Frontiers · Apr 2, 2026
Meta-analysis: Zinc supplements show time-dependent efficacy in preventing oral mucositis after chemoradiotherapy Can a simple mineral help cancer patients avoid painful mouth sores from treatment? New analysis says yes, with timing being key
· Mar 30, 2026
Photobiomodulation reduces severe oral mucositis (RR 0.46) and pain (RR 0.35) in head and neck cancer patients Can light therapy ease the brutal mouth sores and pain of head and neck cancer treatment? A review of 30 studies suggests it can
· Mar 30, 2026